When to reassess
Recurrent symptoms despite, or intolerance of, an antiarrhythmic drug can justify an ablation assessment. [1]
PULSED FIELD ABLATION / TREATMENT CHOICES
Paroxysmal AF after medication fails: when to consider catheter ablation
More than one option
PFA, radiofrequency and cryoballoon are catheter-ablation options; PFA is not automatically the best one. [3]
Keep stroke prevention separate
A successful rhythm result is not permission to stop anticoagulation. [2]
Medication failure is a reason to reassess the treatment plan, not a requirement to choose PFA immediately. The specialist needs to confirm your AF pattern, the effect on daily life and what happened with previous treatment before matching the next option to you. [1]
What “medication has failed” means for the next decision
Paroxysmal AF is an intermittent pattern: episodes come and go. The evidence discussed here concerns people whose AF continues to recur despite drug treatment. Resistance to a medicine and intolerance of its adverse effects are both reasons to revisit the plan; neither tells you which ablation energy to choose. [4][3][1]
The 2024 international ablation consensus supports catheter ablation for symptomatic recurrent paroxysmal or persistent AF after resistance or intolerance to at least one antiarrhythmic drug. Selected symptomatic patients can also consider ablation as first-line treatment. That broader clinical recommendation is not the same as eligibility for every PFA device. [1][5]
Two goals: reduce rhythm symptoms and prevent stroke
Catheter ablation aims to improve rhythm control and reduce arrhythmia-related symptoms. It does not replace a separate assessment of stroke risk. Feeling well or having no obvious palpitations after treatment does not establish that anticoagulation is no longer needed. [1][2]
After AF ablation, the consensus recommends anticoagulation for at least two months. Beyond that early period, the decision depends on stroke risk rather than presumed procedural success. Keep the medicine plan with your treating clinician instead of treating a good rhythm result as a stopping rule. [2]
The choices to compare after drug failure
A medication review remains part of the decision: take the names, doses, benefits and unwanted effects of previous antiarrhythmic treatment to the appointment. Discuss whether a further medicine strategy is appropriate or whether recurrent symptoms make catheter ablation the preferred next step. Do not change doses while arranging the assessment. [1]
If you choose ablation, established thermal approaches include radiofrequency, which heats tissue, and cryoballoon, which freezes it. PFA uses electrical pulses. These are different ways to deliver catheter treatment, not a ladder in which the newest method must be best. [1][3]
ADVENT randomized 305 patients to PFA and 302 to radiofrequency or cryoballoon ablation. All had drug-refractory paroxysmal AF. At one year, the estimated probability of meeting its composite effectiveness endpoint was 73.3% with PFA and 71.3% with pooled thermal ablation. This supported noninferiority, not superiority. [3]
The endpoint combined freedom from initial procedural failure, documented atrial tachyarrhythmia after a three-month blanking period, antiarrhythmic drug use, cardioversion and repeat ablation. It is not a lifetime cure rate, a personal forecast or evidence that PFA beats radiofrequency and cryoballoon separately. [3]
Balance symptom benefit against procedure risks
PFA can limit injury to nearby tissue, but it is still a catheter procedure. Cleveland Clinic lists bruising at the groin, a slow heart rate, temporary phrenic nerve stunning, fluid around the heart and stroke among its possible complications. The decision is not simply whether a medicine has failed: the expected symptom benefit must justify the procedural risks for you. [6]
What the next clinical assessment needs to establish
Use the consultation to connect your symptom history with documented rhythm and heart function. The ESC consensus summary specifies an ECG and echocardiogram before ablation. Some patients also need CT or transoesophageal echocardiography to exclude a clot in the heart. These tests are selected by the team, not ordered as a universal travel package. [1]
Bring prior rhythm recordings, the medication list and previous heart-test reports if you have them. The practical outcome should be a documented treatment choice and an individualized preparation and anticoagulation plan—not simply a booking for the newest device. Follow the team’s specific instructions about blood thinners before any procedure. [1]
Assessment routes and financial planning
The routes below are institutional or clinician assessment contacts. They are not proof that you qualify for PFA, that a place is currently available or that the treatment is covered by insurance. Obtain an individual written estimate rather than using a consultation fee as the procedure price. [7][8]
Cleveland Clinic — Northeast Ohio assessment route
Cleveland Clinic reported routine atrial PFA use in May 2025, including FARAPULSE and the dual-energy Sphere-9/Affera system. Its arrhythmia service lists 800.659.7822 for Northeast Ohio. The Northeast Ohio assessment service can route your case to the appropriate team and treatment location. [9][10][11][12][13]
The official patient price-list page provides an individual estimator route; billing assistance is available at 216.445.6249 or 866.621.6385. Hospital/facility charges and some anesthesiology, radiology or laboratory services may be billed separately under the institution's general policy. [9][10][11][12][13]
The Harley Street Clinic, London — Dr Oliver Segal
HCA documented Affera PFA at The Harley Street Clinic in December 2025. Dr Oliver Segal's official profile lists electrophysiology and pulsed field ablation; his practice site specifically describes Affera-based PFA. Consultations are available through his practice, including telephone/video options; procedures take place at The Harley Street Clinic on Weymouth Street. Practice appointments: 020 3553 9370. [14][15][16][17][18]
The official HCA profile lists £350 for a new consultation and £350 for follow-up. These are consultation fees—not PFA treatment prices. HCA's self-pay team provides individual estimates; its general payment policy separates consultant fees from hospital charges. Use the written procedure-specific estimate to establish the final inclusions rather than treating a consultation price as an ablation price. [14][15][16][17][18]
Arrange an AF treatment assessment
Bookimed can help you organize an assessment after medication has not controlled your AF symptoms. Share the AF diagnosis and previous treatment history with the clinical team.
Sources and further reading
- ESC (2024): international consensus on AF catheter ablation
- 2024 EHRA/HRS/APHRS/LAHRS expert consensus — full text
- ADVENT (2023): randomized PFA versus pooled thermal ablation — primary abstract
- ClinicalTrials.gov NCT04612244: ADVENT protocol and reported results
- FDA FARAPULSE supplement P230030S012 (January 12, 2026): approved indications
- Cleveland Clinic: pulsed field ablation, recovery and precautions
- my.clevelandclinic.org — patient-price-lists
- www.hcahealthcare.co.uk — paying-for-medical-treatment
- Cleveland Clinic Consult QD (May 2025): institutional PFA use and systems
- Cleveland Clinic: billing and financial assistance contacts
- Cleveland Clinic: patient price lists and individual estimates
- Cleveland Clinic: understanding separate bills and facility fees
- Cleveland Clinic: arrhythmia assessment service
- HCA Healthcare UK: Affera introduction at The Harley Street Clinic
- HCA: self-pay enquiry route
- Dr Oliver Segal: official practice, PFA and appointments
- HCA: payment policy and self-pay estimates
- HCA: Dr Oliver Segal profile and consultation fees